Advertisement

Topics

Search Results for "Psa Increased After Negative Biopsy"

10:01 EST 16th January 2017 | BioPortfolio

Matching Channels

Matching News

MRI has a role to play after negative prostate biopsy

(HealthDay)—Magnetic resonance imaging (MRI) and MRI-targeted biopsies have a role in the diagnosis and treatment of patients with a prior negative prostate biopsy, according to a review published i...

Guidelines developed for prostate MRI after negative biopsy

(HealthDay)—In a consensus statement from the American Urological Association and Society of Abdominal Radiology, published in the December issue of The Journal of Urology, guidelines are presented ...

How should patients be monitored for prostate cancer after a negative biopsy?

(Elsevier Health Sciences) An expert panel of urologists and radiologists from the American Urological Association (AUA) and the Society of Abdominal Radiology (SAR) has published a set of consensus s...

[Comment] Is a negative prostate biopsy a risk factor for a prostate cancer related death?

About 30 years ago, Thomas Stamey persuaded urologists to abandon a diagnostic approach to prostate cancer that was predicated on measurable disease to one that was not.1 The new and apparently better...

Make the Diagnosis: Lesion Decision

(MedPage Today) -- Case Findings: A 39-year-old female presents with a back lesion (depicted below) observed during a physical examination when the patient was seen for a chronic cough. Upon biopsy, t...

Biopsy Devices Current and Future Players Prices from USD $3500

Biopsy Devices Current and Future PlayersSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is sus...

Precision Biopsy expands clinical trial of ClariCore biopsy system to include prostate cancer patients

Precision Biopsy announced that its application for an Investigational Device Exemption (IDE) was approved by the U.S. Food and Drug Administration (FDA), allowing the company to expand its clinical t...

Biopsy Devices US Analysis and Market Forecasts Prices from USD $4450

Biopsy Devices US Analysis and Market ForecastsSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient ...

Matching PubMed Articles

Management of men with previous negative prostate biopsy.

Up to 70% of prostate biopsies are negative in men with suspected prostate cancer. Because of inherent limitations in biopsy strategies, a significant proportion of cancers are missed on initial biops...

Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.

The purpose of this study was to evaluate the prostate cancer yield rate of targeted transrectal ultrasound (TRUS)-guided biopsy with cognitive magnetic resonance imaging (MRI) registration without co...

Multiple biopsy passes and the risk of complications of percutaneous liver biopsy.

To minimize the sample variability of liver biopsy, the tissue length should be at least 25 mm. Consequently, more than one biopsy pass is needed with cutting biopsy needles. We aimed to investigate...

Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan.

Sentinel lymph node (SLN) biopsy is now accepted as the standard of care for axillary staging in women with node-negative breast cancer. Currently, dye, radioisotope (RI), and fluorescence indocyanine...

Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study.

The omission of axillary lymph node dissection (ALND) in patients with breast cancer with a negative finding on sentinel node biopsy (SNB) has reduced arm morbidity substantially. Early follow-up repo...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement